Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy

Background and objectivesSeveral autoantibodies against proteins located at the node of Ranvier has been identified in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the last few years. Then a new concept, autoimmune nodo-paranodopathies was proposed. Cases of Caspr1 autoa...

Full description

Bibliographic Details
Main Authors: Lili Liu, Juanjuan Chen, Yue Zhang, Jun Wu, Jun Hu, Zhijian Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.986018/full
_version_ 1828733698767323136
author Lili Liu
Juanjuan Chen
Yue Zhang
Jun Wu
Jun Hu
Zhijian Lin
author_facet Lili Liu
Juanjuan Chen
Yue Zhang
Jun Wu
Jun Hu
Zhijian Lin
author_sort Lili Liu
collection DOAJ
description Background and objectivesSeveral autoantibodies against proteins located at the node of Ranvier has been identified in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the last few years. Then a new concept, autoimmune nodo-paranodopathies was proposed. Cases of Caspr1 autoantibodies are the most rare. Here we describe an anti-Caspr1 nodopathy patient, summarized his clinical, physiological and pathological features.Case presentationWe present the case of a 56-year-old male patient with proprioceptive loss, ataxia, coarse tremor and distal limb weakness without any painess and cranial involvement. Electrophysiological studies showed prolonged distal motor latencies, conduction slowing and reduced amplitude distal compound muscle action potential (CMAP) amplitude. Antibodies against the nodes of Ranvier in serum samples revealed a positive finding for the anti-Caspr1 antibody (1:10).Myelinated fiber loss could be revealed in nerve biopsy. Longitudinal ultrathin sections of the nodal region was discovered in electron microscope, the paranodal/nodal architecture was destructed. It was lack of transverse bands and enlargement of the space between the axon and the paranodal loops was seen. The patient improved obviously after three times immunoadsorption(IA) therapy.ConclusionAnti-Caspr1 nodopathy patient may present atypical symptoms without any neuropathic pain and cranial palsy. The destruction of paranodal/nodal architecture could be observed in nerve biopsy, which may be caused by the lost of axoglial complex formed by NF155, CNTN1 and Caspr1. Antibodies detection is important for the diagnosis, while IA therapy could be regarded as an option for the patients allergic to rituximab (RTX).
first_indexed 2024-04-12T22:35:14Z
format Article
id doaj.art-bb03da2134a6486483ad3b922ab9f3d0
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T22:35:14Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bb03da2134a6486483ad3b922ab9f3d02022-12-22T03:13:53ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-09-011310.3389/fimmu.2022.986018986018Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathyLili Liu0Juanjuan Chen1Yue Zhang2Jun Wu3Jun Hu4Zhijian Lin5Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, ChinaDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen, ChinaDepartment of Nephrology, Peking University Shenzhen Hospital, Shenzhen, ChinaDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen, ChinaDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen, ChinaDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen, ChinaBackground and objectivesSeveral autoantibodies against proteins located at the node of Ranvier has been identified in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the last few years. Then a new concept, autoimmune nodo-paranodopathies was proposed. Cases of Caspr1 autoantibodies are the most rare. Here we describe an anti-Caspr1 nodopathy patient, summarized his clinical, physiological and pathological features.Case presentationWe present the case of a 56-year-old male patient with proprioceptive loss, ataxia, coarse tremor and distal limb weakness without any painess and cranial involvement. Electrophysiological studies showed prolonged distal motor latencies, conduction slowing and reduced amplitude distal compound muscle action potential (CMAP) amplitude. Antibodies against the nodes of Ranvier in serum samples revealed a positive finding for the anti-Caspr1 antibody (1:10).Myelinated fiber loss could be revealed in nerve biopsy. Longitudinal ultrathin sections of the nodal region was discovered in electron microscope, the paranodal/nodal architecture was destructed. It was lack of transverse bands and enlargement of the space between the axon and the paranodal loops was seen. The patient improved obviously after three times immunoadsorption(IA) therapy.ConclusionAnti-Caspr1 nodopathy patient may present atypical symptoms without any neuropathic pain and cranial palsy. The destruction of paranodal/nodal architecture could be observed in nerve biopsy, which may be caused by the lost of axoglial complex formed by NF155, CNTN1 and Caspr1. Antibodies detection is important for the diagnosis, while IA therapy could be regarded as an option for the patients allergic to rituximab (RTX).https://www.frontiersin.org/articles/10.3389/fimmu.2022.986018/fullanti-Caspr1 antibodyCIDPnerve biopsynodo-paranodopathiesIA therapy
spellingShingle Lili Liu
Juanjuan Chen
Yue Zhang
Jun Wu
Jun Hu
Zhijian Lin
Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
Frontiers in Immunology
anti-Caspr1 antibody
CIDP
nerve biopsy
nodo-paranodopathies
IA therapy
title Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
title_full Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
title_fullStr Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
title_full_unstemmed Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
title_short Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
title_sort case report immunoadsorption therapy for anti caspr1 antibody associated nodopathy
topic anti-Caspr1 antibody
CIDP
nerve biopsy
nodo-paranodopathies
IA therapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.986018/full
work_keys_str_mv AT lililiu casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy
AT juanjuanchen casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy
AT yuezhang casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy
AT junwu casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy
AT junhu casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy
AT zhijianlin casereportimmunoadsorptiontherapyforanticaspr1antibodyassociatednodopathy